Filtered By:
Specialty: Cardiovascular & Thoracic Surgery
Condition: Patent Foramen Ovale

This page shows you your search results in order of relevance. This is page number 3.

Order by Relevance | Date

Total 100 results found since Jan 2013.

Left atrial appendage occlusion
EuroIntervention. 2023 Feb 6;18(13):e1038-e1065. doi: 10.4244/EIJ-D-22-00627.ABSTRACTPrevention of stroke represents a goal of primary importance in health systems due to its associated morbidity and mortality. As several patient groups with increased stroke rates have been identified, multiple approaches have been developed and implemented: oral anticoagulation (OAC) for patients with atrial fibrillation, surgical and percutaneous revascularisation in patients with carotid disease, device closure for patients with patent foramen ovale, and now, left atrial appendage occlusion (LAAO) for selected patients with non-valvular...
Source: EuroIntervention - February 10, 2023 Category: Cardiovascular & Thoracic Surgery Authors: David R Holmes Kasper Korsholm Josep Rod és-Cabau Jacqueline Saw Sergio Berti Mohamad A Alkhouli Source Type: research

Amplatzer left atrial appendage occlusion: Single center 10‐year experience
ConclusionLAA closure may be a good alternative to oral anticoagulation. This hypothesis needs to be tested in a randomized clinical trial to ensure that all potential biases of this observational study are accounted for. © 2013 Wiley Periodicals, Inc.
Source: Catheterization and Cardiovascular Interventions - February 14, 2013 Category: Cardiovascular & Thoracic Surgery Authors: Fabian Nietlispach, Steffen Gloekler, René Krause, Samera Shakir, Michael Schmid, Ahmed A. Khattab, Peter Wenaweser, Stephan Windecker, Bernhard Meier Tags: Original Studies Source Type: research

Successful percutaneous transcatheter patent foramen ovale closure through the right internal jugular vein using a steerable catheter
We describe the successful closure of a PFO using the right internal jugular venous approach and a deflectable catheter delivery system in a patient with a PFO, recurrent stroke and an inferior vena cava filter. © 2013 Wiley Periodicals, Inc.
Source: Catheterization and Cardiovascular Interventions - February 14, 2013 Category: Cardiovascular & Thoracic Surgery Authors: Sebastien Hascoet, Alain Fraisse, Meyer Elbaz Tags: Case Report Source Type: research

Transcatheter PFO closure with GORE® SEPTAL OCCLUDER: early and mid‐term clinical results
Conclusion: GORE® Septal Occluder is an easy, safe and effective device in closing PFO. © 2013 Wiley Periodicals, Inc.
Source: Catheterization and Cardiovascular Interventions - July 3, 2013 Category: Cardiovascular & Thoracic Surgery Authors: Gianfranco Butera, Antonio Saracino, Paolo Danna, Paolo Sganzerla, Massimo Chessa, Mario Carminati Tags: Original Study Source Type: research

Device closure of patent foramen ovale in cryptogenic stroke: Still stuck in Hamlet Mode
Source: Catheterization and Cardiovascular Interventions - September 13, 2013 Category: Cardiovascular & Thoracic Surgery Authors: Abdur Khan, Aref Binabdulhak, Ehab Eltahawy Tags: Letter to the Editor Source Type: research

Transseptal puncture to facilitate device closure of “long‐tunnel” patent foramen ovale
Conclusion Though not without risk, transseptal puncture can be a valuable tool for facilitating device closure of long‐tunnel type PFOs. GORE® HELEX® Septal Occluder may be an effective option for facilitating device closure for patients with long‐tunnel type PFO. © 2014 Wiley Periodicals, Inc.
Source: Catheterization and Cardiovascular Interventions - November 7, 2014 Category: Cardiovascular & Thoracic Surgery Authors: Alex J. Thompson, Donald J. Hagler, Nathaniel W. Taggart Tags: Original Studies Source Type: research

PFO closure with only fluoroscopic guidance: 7 years real world single centre experience
Conclusions. In our experience Fluoro‐G PFO closure was performed mainly in cases of simple anatomy, with similar results in terms of safety and efficacy compared to Echo‐G cases. Both fluoroscopy and total procedural times were lower in the Fluo‐G cases. © 2014 Wiley Periodicals, Inc.
Source: Catheterization and Cardiovascular Interventions - November 8, 2014 Category: Cardiovascular & Thoracic Surgery Authors: Antonio Mangieri, Cosmo Godino, Matteo Montorfano, Francesco Arioli, Isabella Rosa, Silvia Ajello, Daniela Piraino, Alberto Monello, Anna Giulia Pavon, Giacomo Viani, Valeria Magni, Alberto Cappelletti, Alberto Margonato, Antonio Colombo Tags: Original Studies Source Type: research

The Flatstent versus the conventional umbrella devices in the percutaneous closure of patent foramen ovale
Conclusion: No difference was found in closure or complication rates between the Flatstent and the umbrella devices. With appropriate pre‐assessment of the PFO anatomy, the Flatstent works as a safe and effective method of treating the PFO from within the tunnel, especially in those with long tunnel PFOs. Longer follow up is needed to establish superiority. This article is protected by copyright. All rights reserved.
Source: Catheterization and Cardiovascular Interventions - November 20, 2014 Category: Cardiovascular & Thoracic Surgery Authors: Mert Aral, Michael Mullen Tags: Original Studies Source Type: research

PFO closure with only fluoroscopic guidance: 7 years real‐world single centre experience
ConclusionsIn our experience Fluoro‐G PFO closure was performed mainly in cases of simple anatomy, with similar results in terms of safety and efficacy compared to Echo‐G cases. Both fluoroscopy and total procedural times were lower in the Fluo‐G cases. © 2014 Wiley Periodicals, Inc.
Source: Catheterization and Cardiovascular Interventions - March 19, 2015 Category: Cardiovascular & Thoracic Surgery Authors: Antonio Mangieri, Cosmo Godino, Matteo Montorfano, Francesco Arioli, Isabella Rosa, Silvia Ajello, Daniela Piraino, Alberto Monello, Anna Giulia Pavon, Giacomo Viani, Valeria Magni, Alberto Cappelletti, Alberto Margonato, Antonio Colombo Tags: Pediatric and Congenital Heart Disease Source Type: research

Cryptogenic Stroke with a Patent Foramen Ovale:
ABSTRACT More than one third of ischemic strokes have an unidentifiable cause. Patent foramen ovale (PFO) plays a controversial role in this subset of patients. The evidence for and against the hypothesis of paradoxical embolism is reviewed and we discuss the optimal management of a PFO under different circumstances.
Source: Journal of Cardiac Surgery - January 19, 2016 Category: Cardiovascular & Thoracic Surgery Authors: Kareem Bedeir, John Volpi, Basel Ramlawi Tags: Review Article Source Type: research

Patent foramen ovale: indications for closure and techniques.
Authors: Taramasso M, Nietlispach F, Maisano F, Meier B Abstract Non-surgical closure of the patent foramen ovale (PFO) has been possible for 40 years and proved safe in probably a million cases performed worldwide. Nonetheless, indications are still restricted as only a few are supported by randomised data. Paradoxical embolism through a PFO causes stroke, myocardial infarction, and visceral or peripheral ischaemia. The PFO is a likely mediator of migraine, diving or high altitude sickness, dyspnoea, and sleep apnoea problems. As untoward effects of a PFO are rare and spaced widely timewise, large cohorts and long...
Source: EuroIntervention - May 15, 2016 Category: Cardiovascular & Thoracic Surgery Tags: EuroIntervention Source Type: research

The Society of Thoracic Surgeons Mitral Valve Repair/Replacement Plus Coronary Artery Bypass Grafting Composite Score: A Report of The Society of Thoracic Surgeons Quality Measurement Task Force
Conclusions An STS composite performance measure was developed for MVRR + CABG operations. This measure may be useful for outcome assessment, quality improvement, patient counseling, clinical research, and public reporting.
Source: The Annals of Thoracic Surgery - December 6, 2016 Category: Cardiovascular & Thoracic Surgery Source Type: research

The Society of Thoracic Surgeons Mitral Valve Repair/Replacement Plus Coronary Artery Bypass Grafting Composite Score: A Report of The Society of Thoracic Surgeons Quality Measurement Task Force.
CONCLUSIONS: An STS composite performance measure was developed for MVRR + CABG operations. This measure may be useful for outcome assessment, quality improvement, patient counseling, clinical research, and public reporting. PMID: 27938886 [PubMed - as supplied by publisher]
Source: The Annals of Thoracic Surgery - December 5, 2016 Category: Cardiovascular & Thoracic Surgery Authors: Rankin JS, Badhwar V, He X, Jacobs JP, Gammie JS, Furnary AP, Fazzalari FL, Han J, O'Brien SM, Shahian DM Tags: Ann Thorac Surg Source Type: research